The potential for lifestyle change to influence the progression of impaired glucose tolerance to non-insulin-dependent diabetes mellitus

Diabetic Medicine

Volumn 13, Issue 11, 1996, Pages 938-945

  Bourn, Diane M ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Impaired glucose tolerance; Intervention trials; Non insulin dependent diabetes mellitus; Risk factors

Indexed keywords

GLIPIZIDE; TOLBUTAMIDE;

DIET; HUMAN; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; REVIEW; RISK FACTOR; TYPES OF STUDY;

DIABETES MELLITUS, TYPE 2; DIABETIC DIET; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEALTH BEHAVIOR; HUMANS; INCIDENCE; LIFE STYLE; PATIENT EDUCATION; RISK FACTORS;

EID: 0029835438     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199611)13:11<938::AID-DIA274>3.0.CO;2-P     Document Type: Review

References (55)

1. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057.
2. WHO Expert Committee. Diabetes Mellitus. Technical Report Series No. 646. Geneva: WHO, 1980.
3. World Health Organization. Diabetes Mellitus. Report of a WHO study group. Technical Report Series No. 727. Geneva: WHO, 1985.
4. King H, Rewers M, WHO Ad Hoc Diabetes Reporting Group. Global estimates for the prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 1993; 16: 157-177.
5. Ohmura T, Ueda K, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, et al. Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama study. Diabetologia 1993; 36: 1198-1203.
6. Sekikawa A, Tominaga M, Takahashi K, Eguchi H, Igarashi M, Ohnuma H, et al. Prevalence of diabetes and impaired glucose tolerance in Funagata area, Japan. Diabetes Care 1993; 16: 570-574.
7. Park Y, Yoo K, Lee H, Kim Y, Koh C-H, Shin Y, et al. Prevalence of diabetes and IGT in Yonchon County, South Korea. Diabetes Care 1995; 18: 545-548.
8. Dowse GK, Spark RA, Mavo B, Hodge AM, Erasmus RT, Gwalimu M, et al. Extraordinary prevalence of non-insulin-dependent diabetes mellitus and bimodal plasma glucose distribution in the Wanigela people of Papua New Guinea. Med J Aust 1994; 160: 767-774.
9. Dowse GK, Zimmet PZ, King H. Relationship between prevalence of impaired glucose tolerance and NIDDM in a population. Diabetes Care 1991; 14: 968-974.
10. Yudkin JS, Alberti KGMM, McLarty DG, Swai ABM. Impaired glucose tolerance. Is it a risk factor or a diagnostic ragbag? Br Med J 1990; 301: 397-402.
11. Charles MA, Fontbonne A, Thibult N, Warnet J-M, Rosselin GE, Eschwege E. Risk factors for NIDDM in white population. Paris prospective study. Diabetes 1991 ; 40: 796-799.
12. Motala AA, Omar MAK, Gouws E. High risk of progression to NIDDM in South-African Indians with impaired glucose tolerance. Diabetes 1993; 42: 556-563.
13. Yamada T, Aizawa T, Nagasawa Y, Ishihara M, Komatsu M, Komiya I, et al. Ten-year follow-up of Japanese overweight subjects with impaired glucose tolerance; identification of a diabetes-prone subpopulation. Int Med 1992; 31: 877-884.
14. Tukuitonga CF. Progress of impaired glucose tolerance to diabetes mellitus among Niueans. NZ Med J 1990; 103: 351-353.
15. Cederholm J, Wibell L. What causes impaired glucose tolerance to deteriorate or normalize? Scand J Clin Lab Invest 1992; 52: 491-495.
16. Rios J, Gomez R, Roman V, Villa A, Perez-e B, Gomez-Perez F, et al. High rate of progression of impaired glucose tolerance (IGT) to diabetes (DM) in a genetically susceptible population (Abstract). Diabetes 1995; 44 (suppl 1): 184A.
17. Ritchie A, Norris R, Antonucci T. Practical experience recruiting subjects with impaired glucose tolerance for clinical trials (Abstract). Diabetes 1995; 44 (suppl 1 ): 215A.
18. Jarrett RJ, Keen H, Fuller JH, McCartney M. Worsening to diabetes in men with impaired glucose tolerance ('borderline diabetes'). Diabetologia 1979; 16: 25-30.
19. Jarrett RJ, Keen H, McCartney P. The Whitehall study: ten year follow-up report on men with impaired glucose tolerance with reference to worsening to diabetes and predictors of death. Diabetic Med 1984; 1: 279-283.
20. Keen H, Jarrett RJ, McCartney P. The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes. Diabetologia 1982; 22: 73-78.
21. Sartor G, Schersten B, Carlstrom S, Melander A, Norden A, Persson G. Ten year follow-up of subjects with impaired glucose tolerance. Prevention of diabetes by tolbutamide and diet regulation. Diabetes 1980; 29: 41-49.
22. Papoz L, Job D, Eschwege E, Aboulker JP, Cubeau J, Pequignot G, et al. Effect of oral hypoglycemic drugs on glucose tolerance and insulin secretion in borderline diabetic patients. Diabetologia 1978; 15: 373-380.
23. Tan MH, Graham CA, Bradley RF, Gleason RE, Soeldner JS. The effect of long-term therapy with oral hypoglycemic agents on the oral glucose tolerance test dynamics in male chemical diabetics. Diabetes 1977; 26: 561-570.
24. Ratzmann KP, Witt S, Schulz B. The effect of long-term glibenclamide treatment on glucose tolerance, insulin secretion and serum lipids in subjects with impaired glucose tolerance. Diabetes Metabolisme (Paris) 1983; 9: 87-93.
25. Bitzen P-O, Melander A, Schersten B, Wahlin-Boll E. The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia. Eur J Clin Pharmacol 1988; 35: 31-37.
26. Pontiroli AE, Perfetti MG, Pozza G. Acute effect of glipizide on glucose tolerance in obesity and diabetes mellitus (NIDDM). Eur J Clin Pharmacol 1991 ; 40: 23-26.
27. Chiasson J-L, Josse RG, Leiter LA, Mihic M, Nathan DM, Plamason C, et al. Can we prevent the development of non-insulin-dependent diabetes mellitus (Abstract) Diabetes 1995; 44: (suppl 1): 62A.
28. Melander A, Bitzen P-O, Sartor G, Schersten B, Wahlin-Boll E. Will sulfonylurea treatment of impaired glucose tolerance delay development and complications of NIDDM? Diabetes Care 1990; 13 (suppl 3): 53-58.
29. Bitzen P-O, Melander A, Schersten B, Svensson M. Efficacy of dietary regulation in primary health care patients with hyperglycemia detected by screening. Diabetic Med 1988; 5: 640-647.
30. Eriksson K-F, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. Diabetologia 1991; 34: 891-898.
31. Page RCL, Harnden KE, Cook JTE, Turner RC. Can lifestyles of subjects with impaired glucose tolerance be changed? A feasibility study. Diabetic Med 1992; 9: 562-566.
32. Bourn D, Mann J, McSkimming B, Waldron M, Wishart J. Impaired glucose tolerance and NIDDM: does a lifestyle intervention program have an effect? Diabetes Care 1994; 17: 1311-1319.
33. Pan X, Li G, Hu Y, Zuoxin A, Jixing W, Bennett PH, et al. Effect of dietary and/or exercise interventions on incidence of diabetes in 530 subjects with IGT - the Da-Qing IGT and diabetes study. Abstract presented at the International Diabetes Federation Congress, Kobe, Japan, November 1994.
34. Pan X, Li G, Hu Y. Effect of dietary and/or exercise intervention on incidence of diabetes in 530 subjects with impaired glucose tolerance from 1986-1992. Chung-Hua Nei Ko Tsa Chih Chinese J Intern Med 1995; 34: 108-112.
35. Page RCL, Harnden KE, Walravens NKN, Onslow C, Sutton P, Levy JC, et al. 'Healthy living' and sulphonylurea therapy have different effects on glucose tolerance and risk factors for vascular disease in subjects with impaired glucose tolerance. Quart J Med 1993; 86: 145-154.
36. Bourn DM, Mann JI. The 3yr follow-up of subjects with IGT or NIDDM in a diet and exercise intervention programme. Diab Nutr Metab (in press).
37. Hughes VA, Fiatarone MA, Fielding RA, Ferrara CM, Elahi D, Evans WJ. Long-term effects of a high-carbohydrate diet and exercise on insulin action in older subjects with impaired glucose tolerance. Am J Clin Nutr 1995; 62: 426-433.
38. Lindgarde F, Eriksson K-F, Lithell H, Saltin B. Coupling between dietary changes, reduced body weight, muscle fibre size and improved glucose tolerance in middle aged men with impaired glucose tolerance. Acta Med Scand 1982; 212: 99-106.
39. Long SD, O'Brien K, MacDonald KG, Leggett-Frazier N, Swanson MS, Pories WJ, et al. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. Diabetes Care 1994; 17: 372-375.
40. Fasching P, Ratheiser K, Waldhausl W, Rohac M, Osterrode W, Nowotny P, et al. Metabolic effects of fishoil supplementation in patients with impaired glucose tolerance. Diabetes 1991; 40: 583-589.
41. Schwab U, Sarkkinen E, Niskanen L, Uusitupa M. Effects of two fat-modified diets on glucose and lipid metabolism in subjects with IGT (Abstract). Diabetes 1995; 44: (suppl 1): 87A.
42. Gonzelez C, Stern MP, Mitchell BD, Valdez RA, Haffner SM, Perez BA. Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico city and San Antonio, Texas. Diabetes Care 1994; 17: 397-404.
43. Lerman-Garber I, Ichazo-Cerro S, Zamora-Gonzalez J, Cardoso-Saldana G, Posadas-Romero C. Effect of a high-monounsaturated fat diet enriched with avocado in NIDDM patients. Diabetes Care 1994; 17: 311-315.
44. Rasmussen OW, Thomsen C, Hansen KW, Vesterlund M, Winther E, Hermansen K. Effects on blood pressure, glucose, and lipid levels of a high-monounsaturated fat diet compared with a high-carbohydrate diet in NIDDM subjects. Diabetes Care 1993; 16: 1565-1571.
45. Campbell LV, Marmot PE, Dyer JA, Borkman M, Storlein LH. The high-monounsaturated fat diet as a practical alternative for NIDDM. Diabetes Care 1994; 17: 177-182.
46. Walker KZ, Nicholson GC, O'Dea K, Muir JG. Dietary composition, body weight and NIDDM. Diabetes Care 1995; 18: 401-403.
47. Chen Y-DI, Hollenbeck CB, Coulston AM, Reaven GM, Zhou M-Y. Why do low-fat high-carbohydrate diets accentuate postprandial lipemia in patients with NIDDM? Diabetes Care 1995; 18: 10-16.
48. Garg A, Grundy SM, Unger RH. Comparison of effects of high and low carbohydrate diets on plasma lipoproteins and insulin sensitivity in patients with mild NIDDM. Diabetes 1992; 41: 1278-1285.
49. Milne RM, Mann JI, Chisholm AW, Williams SM. Long-term comparison of three dietary prescriptions in the treatment of NIDDM. Diabetes Care 1994; 17: 74-80.
50. American Diabetes Association. Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care 1995; 18: 16-19.
51. Horrocks PM, Blackmore R, Wright AD. A long-term follow-up of dietary advice in maturity onset diabetes: the experience of one centre in the UK prospective study. Diabetic Med 1987; 4: 241-244.
52. Laitinen JH, Ahola IE, Sarkkinen ES, Winberg RL, Harmaakorpi-livonen PA, Uusitupa MI. Impact of intensified dietary therapy on energy and nutrient intakes and fatty acid composition of serum lipids in patients with recently diagnosed non-insulin-dependent diabetes mellitus. J Am Diet Assoc 1993; 93: 276-283.
53. Close EJ, Wiles PG, Lockton JA, Walmsley D, Oldham J, Wales JK. Diabetic diets and nutritional recommendations: what happens in real life? Diabetic Med 1992; 9: 181-188.
54. National Institutes of Health. Non-insulin dependent diabetes primary prevention trial. NIH Guide Grants Contacts 1993; 22: 1-20.
55. Anderson RM. Patient empowerment and the traditional medical model. A case of irreconcilable differences? Diabetes Care 1995; 18: 412-415.